BOARD OF DIRECTORS

Our board of directors bring tremendous experience, visionary thinking and a shared commitment to excellence, creativity and innovation

IRIS BINCOVICH

Interim Executive Chair

20-year Healthcare and Biotech industry veteran. Led hundreds of successful global transactions in the OTC, cosmetics and dermatology sectors.

InnoCan Pharma Corp is an international company specializing in the development of several drug delivery platforms. Our experienced board of directors consists of experts from various sectors who bring a wealth of experience and knowledge to the company. This includes business professionals, scientists, pharmacologists, and financiers. Together, they provide a powerful combination of business experience, scientific expertise, and financial acumen that ensures the company’s success.

Our directors are actively involved not only in the commercialization of our products, but also in the creation of strategic alliances and partnerships. We understand that in order to create a sustainable business model, we need to constantly evolve and adapt, just like the online gambling industry, a rapidly growing and changing market.

Just as casino en ligne nouveau constantly strive to provide an immersive and unique user experience through their cutting-edge platforms, we at InnoCan are also always looking for opportunities to create innovative solutions for our customers. We are always ahead of the curve, just like the leaders in the online casino industry who have their finger on the pulse of technology and consumer trends.

RONI KAMHI

Over 20 years of experience spanning global retail, e-commerce, healthcare, and AI technology, Roni has established himself as a pioneering entrepreneur and strategic business leader. His expertise encompasses advanced wellness and beauty solutions, digital transformation, analytics, and data-driven decision-making. As a serial founder, he has successfully scaled multiple startups from inception to nine-figure revenues. Roni’s proven track record includes developing and implementing international business strategies that have effectively penetrated new markets and driven global expansion.

PETER BLOCH

Peter Bloch has more than 25 years of experience in leading healthcare and technology companies in the role of Chairman, CEO and previously CFO. This includes experience in both large Pharmaceutical (Sanofi -Aventis) and earlier stage Medical Device and Biotechnology companies (Bionik Laboratories, Tribute Pharmaceuticals and Intellivax).

EYAL FLOM

Mr. Flom has served as the Israeli Pharmaceutical Association legal counsel since April 1995. He has also served as a director of several startup companies in the field of technology and biotech. Mr. Flom obtained his LLM from the Tel Aviv University and his MBA from Derby university (Tel Aviv Campus).

JOSHUA LINTERN

Served as Director, Risk and Insurance, of Dream Unlimited Corp. Mr. Lintern holds a BSc (Hons) in
Environmental Sciences from the University of Guelph and obtained his Certified Risk Manager
status from University of Toronto (Continuing Studies) in 2013.

RALPH C.L. BOSSINO

Mr. Bossino is managing director of Solsken and practices as an independent barrister-at-law since 2014. He serves as a director and member of the investment committee of Rivendell Global (Gibraltar) Ltd., a private real estate investment vehicle focused on European residential properties. Mr. Bossino obtained his LLB (Hons) from King’s College and qualified as a barrister in the UK in 2010.

GET IN TOUCH

Email us - [email protected]

INVESTOR EMAIL ALERTS